Lyterian Therapeutics

Lyterian Therapeutics

Biotechnology Research

South San Francisco, California 1,654 followers

Co-opting physiologically relevant protein homeostatic mechanisms for treating disease

About us

Lyterian Therapeutics derives its name from the Greek word λυτήριος or lutḗrios, that defines the termination, healing, or end of disease. Disease resolution is coordinated by endogenous and exogenous agents that recruit cells and other effectors to the site of injury. We are inspired to learn from the logic that orchestrates homeostatic equilibria and fosters healing in response to disease. At Lyterian Therapeutics, we are committed to developing medicines for patients in need by co-opting physiologically relevant protein homeostatic mechanisms to regulate genetically validated targets.

Website
lyterian.com
Industry
Biotechnology Research
Company size
11-50 employees
Headquarters
South San Francisco, California
Type
Privately Held
Founded
2022
Specialties
Biotechnology and Pharmaceuticals

Locations

  • Primary

    630 Gateway Blvd

    South San Francisco, California 94080, US

    Get directions

Employees at Lyterian Therapeutics

Updates

Similar pages